CanadaBis Capital Inc. (CANB.V)
CAD 0.04
(0.0%)
CAD 0.04
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 4.67 Million CAD | 350.76% |
| 2022 | 1.03 Million CAD | 145.39% |
| 2021 | -2.28 Million CAD | 51.58% |
| 2020 | -4.72 Million CAD | 0.01% |
| 2019 | -4.72 Million CAD | -3311.71% |
| 2018 | -138.36 Thousand CAD | 7.89% |
| 2017 | -150.2 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q3 | 217.78 Thousand CAD | 619.62% |
| 2024 Q1 | 861.46 Thousand CAD | -41.55% |
| 2024 Q2 | 30.1 Thousand CAD | -96.51% |
| 2023 Q1 | 803.7 Thousand CAD | 37.17% |
| 2023 FY | 4.67 Million CAD | 350.76% |
| 2023 Q2 | 1.4 Million CAD | 74.88% |
| 2023 Q4 | 1.47 Million CAD | 48.27% |
| 2023 Q3 | 993.95 Thousand CAD | -29.28% |
| 2022 Q4 | 585.91 Thousand CAD | 192.94% |
| 2022 Q3 | 200.01 Thousand CAD | -49.41% |
| 2022 Q2 | 395.36 Thousand CAD | 375.05% |
| 2022 Q1 | -143.74 Thousand CAD | 86.46% |
| 2022 FY | 1.03 Million CAD | 145.39% |
| 2021 Q4 | -1.06 Million CAD | -723.81% |
| 2021 Q3 | -128.9 Thousand CAD | 72.17% |
| 2021 Q2 | -463.12 Thousand CAD | 38.96% |
| 2021 Q1 | -758.67 Thousand CAD | -299.47% |
| 2021 FY | -2.28 Million CAD | 51.58% |
| 2020 FY | -4.72 Million CAD | 0.01% |
| 2020 Q1 | -2.97 Million CAD | 25.74% |
| 2020 Q3 | -796.28 Thousand CAD | 40.3% |
| 2020 Q2 | -1.33 Million CAD | 55.1% |
| 2020 Q4 | 380.35 Thousand CAD | 147.77% |
| 2019 Q2 | -77.27 Thousand CAD | -422.54% |
| 2019 FY | -4.72 Million CAD | -3311.71% |
| 2019 Q3 | -456.28 Thousand CAD | -490.44% |
| 2019 Q1 | -14.78 Thousand CAD | -42.05% |
| 2019 Q4 | -3.99 Million CAD | -776.57% |
| 2018 FY | -138.36 Thousand CAD | 7.89% |
| 2018 Q3 | -30.72 Thousand CAD | 0.0% |
| 2018 Q4 | -10.41 Thousand CAD | 66.12% |
| 2018 Q1 | -5069.00 CAD | 68.91% |
| 2017 Q4 | -16.3 Thousand CAD | 0.0% |
| 2017 FY | -150.2 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | -2.82 Million CAD | 265.83% |
| Decibel Cannabis Company Inc. | 1.41 Million CAD | -231.224% |
| Delivra Health Brands Inc. | -710 Thousand CAD | 758.717% |
| Entourage Health Corp. | -21.37 Million CAD | 121.877% |
| Lifeist Wellness Inc. | -12.24 Million CAD | 138.179% |
| Cannara Biotech Inc. | 11.88 Million CAD | 60.658% |
| Medicure Inc. | -854 Thousand CAD | 647.645% |
| PharmaCielo Ltd. | -9.7 Million CAD | 148.211% |
| Rubicon Organics Inc. | -1.08 Million CAD | 531.668% |
| BioSyent Inc. | 7.47 Million CAD | 37.401% |
| Voyageur Pharmaceuticals Ltd. | -1.22 Million CAD | 483.053% |